Healius Limited
HLS.AX · ASX
Market closed0.360000-0.015000 (-4.00%)
Key statistics
Previous close0.375000
Open0.375000
Day high0.375000
Day low0.360000
52-week high1.07
52-week low0.300000
Market cap261.42M
Volume4.67M
Average volume4.97M
P/E ratio-1.75
Forward P/E—
EPS-0.21
Dividend yield0.00%
Market context
Why it moved
HLS.AX (Healius) shares fell sharply today amid broad selling pressure and no specific positive catalysts, with investor sentiment weighing on the stock as it drifted lower throughout the session on elevated volume.
What is happening
Recent company-specific developments and publisher coverage.
TradingView · July 3, 2026Healius Expects FY 2026 Group Underlying EBIT Of A$30 Million-A$35 Millionwww.marketscreener.com · May 26, 2026Private Equity Reportedly Lines Up for Healius's Agilex SaleSimply Wall Street · May 17, 2026Healius (ASX:HLS) Valuation After FY26 Guidance Cut And Rising Pathology Labour Cost Pressureswww.intelligentinvestor.com.au · May 14, 2026Healius faces budget issuesMoomoo · May 13, 2026Healius Says Pathology Volumes Had Grown 1.2% in 1HBusiness News Australia · May 13, 2026Healius shares slump 23pc as rising costs hit pathology giant with no relief from federal budgetgrafa.com · May 12, 2026Healius updates FY26 guidance amid strategic review